126 related articles for article (PubMed ID: 38619013)
1. Toxic epidermal necrolysis associated with the use of levetiracetam.
Sierra-Gordillo Y; Peñaranda-Contreras E; Gomez Arbeláez MM; Moreno-Lucero PA
Clin Toxicol (Phila); 2024 Mar; 62(3):201-202. PubMed ID: 38619013
[No Abstract] [Full Text] [Related]
2. Levetiracetam: a possible new inducer of toxic epidermal necrolysis and Stevens-Johnson syndrome in 2 cases.
Duong TA; Haddad C; Valeyrie-Allanore L; Sbidian E; Chosidow O; Wolkenstein P
JAMA Dermatol; 2013 Jan; 149(1):113-5. PubMed ID: 23324778
[No Abstract] [Full Text] [Related]
3. Toxic epidermal necrolysis with isolated neutropenia related to the use of levetiracetam.
Oh SJ; Kwon HI; Moon SH; Ro YS; Ko JY
J Dermatol; 2016 Aug; 43(8):969-71. PubMed ID: 26893076
[No Abstract] [Full Text] [Related]
4. Immediate hypersensitivity reaction to levetiracetam: a case report study.
Hosseini MS; Namazi S
Daru; 2024 Jun; 32(1):435-438. PubMed ID: 37914917
[TBL] [Abstract][Full Text] [Related]
5. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis associated with anticonvulsants in a Japanese population: Matched case-control and cohort studies.
Fukasawa T; Takahashi H; Takahashi K; Tanemura N; Amagai M; Urushihara H
Allergol Int; 2021 Jul; 70(3):335-342. PubMed ID: 33618992
[TBL] [Abstract][Full Text] [Related]
6. Stevens-Johnson syndrome induced by levetiracetam.
Zou LP; Ding CH; Song ZJ; Li XF
Seizure; 2012 Dec; 21(10):823-5. PubMed ID: 23036769
[No Abstract] [Full Text] [Related]
7. Stevens-Johnson syndrome triggered by Levetiracetam-Caution for use with Carbamazepine.
Sawal N; Kanga U; Shukla G; Goyal V; Srivastava AK
Seizure; 2020 Aug; 80():63-64. PubMed ID: 32540638
[No Abstract] [Full Text] [Related]
8. A topical matter: toxic epidermal necrolysis.
Ladizinski B; Sankey C
Am J Med; 2014 Oct; 127(10):931-2. PubMed ID: 24950488
[No Abstract] [Full Text] [Related]
9. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: An Analysis of Triggers and Implications for Improving Prevention.
Miliszewski MA; Kirchhof MG; Sikora S; Papp A; Dutz JP
Am J Med; 2016 Nov; 129(11):1221-1225. PubMed ID: 27086495
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic combination therapy with Stevens-Johnson syndrome and toxic epidermal necrolysis: Analysis of a Japanese pharmacovigilance database.
Noguchi Y; Takaoka M; Hayashi T; Tachi T; Teramachi H
Epilepsia; 2020 Sep; 61(9):1979-1989. PubMed ID: 32761907
[TBL] [Abstract][Full Text] [Related]
11. Dose-related levetiracetam-induced reticulated drug eruption.
Beswick TC; Cohen JB
J Drugs Dermatol; 2010 Apr; 9(4):409-10. PubMed ID: 20514803
[TBL] [Abstract][Full Text] [Related]
12. Stevens-Johnson syndrome and toxic epidermal necrolysis at the University Hospital of the West Indies, Jamaica.
East-Innis AD; Thompson DS
West Indian Med J; 2013 Sep; 62(7):589-92. PubMed ID: 24831894
[TBL] [Abstract][Full Text] [Related]
13. Ethosuximide-induced Stevens-Johnson syndrome/toxic epidermal necrolysis overlap confirmed by patch testing in a child.
Matos AL; Carvalho J; Calado R; Gomes T; Ramos L; Gonçalo M
Contact Dermatitis; 2021 Nov; 85(5):602-604. PubMed ID: 34218457
[No Abstract] [Full Text] [Related]
14. Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.
Frey N; Bodmer M; Bircher A; Jick SS; Meier CR; Spoendlin J
Drug Saf; 2019 Jan; 42(1):55-66. PubMed ID: 30112729
[TBL] [Abstract][Full Text] [Related]
15. Causative Drugs of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Israel.
Maggio N; Firer M; Zaid H; Bederovsky Y; Aboukaoud M; Gandelman-Marton R; Noyman I; Ekstein D; Blatt I; Marom E; Schwartzberg E; Israel S; Ingber A; Brautbar C; Eyal S
J Clin Pharmacol; 2017 Jul; 57(7):823-829. PubMed ID: 28181259
[No Abstract] [Full Text] [Related]
16. Stevens Johnson syndrome/toxic epidermal necrolysis-overlap, induced by lacosamide.
Kardaun SH; Vos BJ; Chandran NS
Eur J Dermatol; 2016 Apr; 26(2):185-6. PubMed ID: 27017922
[No Abstract] [Full Text] [Related]
17. Identifying the incidence of rash, Stevens-Johnson syndrome and toxic epidermal necrolysis in patients taking lamotrigine: a systematic review of 122 randomized controlled trials.
Bloom R; Amber KT
An Bras Dermatol; 2017; 92(1):139-141. PubMed ID: 28225977
[TBL] [Abstract][Full Text] [Related]
18. Oxcarbazepine induced toxic epidermal necrolysis - a rare case report.
Guleria VS; Sharda C; Rana T; Sood AK
Indian J Pharmacol; 2015; 47(4):459-61. PubMed ID: 26288485
[TBL] [Abstract][Full Text] [Related]
19. Rare Red Rashes: A Case Report of Levetiracetam-Induced Cutaneous Reaction and Review of the Literature.
Jones RT; Evans W; Mersfelder TL; Kavanaugh K
Am J Ther; 2016; 23(3):e944-6. PubMed ID: 25259954
[TBL] [Abstract][Full Text] [Related]
20. Comparison of reporting of Stevens-Johnson syndrome and toxic epidermal necrolysis in association with selective COX-2 inhibitors.
La Grenade L; Lee L; Weaver J; Bonnel R; Karwoski C; Governale L; Brinker A
Drug Saf; 2005; 28(10):917-24. PubMed ID: 16180941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
